Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Hyzaar

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Objectives To use Hyzaar and Creatine Phosphate Sodium together for treating hypertensive diastolic dysfunction and observe the… Expand
Review
2012
Review
2012
SummaryAbstractLosartan/hydrochlorothiazide (HCTZ) [Hyzaar®] is a fixed-dose combination of the angiotensin II receptor… Expand
  • table I
  • table II
  • table III
  • table IV
  • table V
2010
2010
Objective To evaluate the effects of hyzaar on the male sexual function in middle-aged hypertensive men.Methods Eighty-six middle… Expand
2009
2009
A method based on a simple liquid-liquid extraction (LLE) followed by high-performance liquid chromatography with negative ion… Expand
2006
2006
Objective To evaluate three schemes of medium and severe idiopathic hypertension treatment. Methods Forty five cases with medium… Expand
Highly Cited
2005
Highly Cited
2005
Previous studies have demonstrated that antihypertensive treatment resets baroreflex control of heart rate (HR) and increases… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
2003
2003
Objective:To compare the effects of HYZAAR(losartan potassium/hydrochlorothiazide) with that of benazepril on essential… Expand
Highly Cited
2002
Highly Cited
2002
Losartan potassium was the first in a new class of potent angiotensin II receptor antagonists which are well-tolerated in the… Expand
2002
2002
Objective: To evaluate the therapeutic effect of Hyzaar on patients with essential hypertension. Methods: Forty patients with… Expand
Review
1996
Review
1996
Adults Angiotensin II receptor blockers (ARBs) as monotherapy are FDA-approved for use in hypertension (all available ARBs… Expand
  • table 1
  • table 2
  • table 3
  • table 4